Blueberry is committed to the development of innovative therapies to treat diseases where infection and inflammation are major factors.
We use cutting-edge nano polymer drug delivery technology to exploit both small molecule and biologic approaches to developing treatments.
Blueberry Therapeutics today announced that it has raised £3 million to progress the development of its topical fungal infection therapies into human clinical trials. The […]
2016-05-13T10:41:14+00:00May 5th, 2016|
Blueberry was delighted to host HRH the Duke of York on Tuesday the 2nd of February when he visited our laboratories during a visit […]
2016-02-09T12:31:02+00:00February 2nd, 2016|
Blueberry Therapeutics Ltd are amongst 80 co-signatories on a declaration at the World Economic Forum in Davos committing to working together to solve the growing […]
2016-05-13T10:40:17+00:00January 22nd, 2016|